MDT vs TECH · P/E 21, rev $36.36B vs P/E 65, rev $1.22B
Medtronic PLC (MDT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MDT and TECH stock pages for the full models.
Not investment advice.